Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

NCT02246075 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Forum has decided not to proceed with this study at this time.

Conditions

Alzheimer's Disease
Dementia
Cognition

Interventions

DRUG: EVP-6124

Sponsor

FORUM Pharmaceuticals Inc

Collaborators

[object Object]